Heart-Sparing Radiation for Thoracic Cancers
Part of Blood & lymphatic, Cancer, Digestive system, Lungs & breathing clinical trials.
This trial tests a new way to plan radiation for cancers in the chest area (like lung, esophageal, or thymus cancers) that aims to protect the heart from high doses of radiation. It is for people who need daily radiation for at least three weeks and who are expected to live more than a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of cancer in the chest, such as non-small cell lung cancer (stage 2B-4), limited stage small cell lung cancer, esophageal cancer, thymoma/thymic carcinoma, or other chest cancers.
- Your planned radiation treatment is given daily (not twice a day) and lasts at least 15 sessions.
- Your heart is expected to receive more than 10% of the radiation dose (over 25 Gy), based on a quick planning scan.
- You have not had radiation to your chest area before that would overlap with this treatment.
- You are able to have an MRI scan and do not have severe heart failure (Class III or IV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a targeted, low-dose radiation treatment to the heart can improve symptoms and outcomes for people with advanced heart failure who cannot have a heart transplant or a mechanical heart pump. The treatment is given as a one-time procedure and aims to reduce the heart's workload and improve its function.
This study looks at how radiation therapy affects the heart in people being treated for lung, esophageal, or breast cancer. By watching the heart during and after treatment, researchers hope to find ways to lower heart side effects.
This study tests a new way of planning radiation therapy for stage 3 lung cancer. By carefully mapping the heart's structure, doctors aim to protect it from radiation and improve treatment safety.
This trial tests an early heart-focused intervention guided by a special heart recording (impedance cardiography) in people with locally advanced, unresectable stage III non-small cell lung cancer. The goal is to improve heart-related safety during planned radiation and chemotherapy, with or without immunotherapy.
This trial tests if a low dose of radiation to the heart can help people with advanced heart failure feel better and improve heart function. It is for patients whose heart failure is stable but severe, and who are already on the best medications.
This study looks at how chest radiation treatment affects the heart and lungs in people with certain lung or esophagus cancers. It may help doctors better predict and prevent these side effects during curative (aimed at cure) radiotherapy.
Hear when a new Non-small Cell Lung Cancer Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.